Caroline Dorsa, MBA is a recently retired financial executive with over 30 years of diverse business leadership in biopharmaceuticals, power generation/regulated utilities, telecommunications and the public sector. Ms. Dorsa has extensive experience in finance, corporate development, accounting and controls, budgeting and planning, internal audit, treasury, investor relations and strategy. Experience on Audit (chair), Finance, Governance, Risk and Compensation Committees. She is currently on the Board of Directors of Biogen and Intellia and was a Board member of Public Service Enterprise Group, Inc. from 2003 to 2009. While she was at Public Service Enterprise Group, Inc., she was active in civic activities as a Board of Trustee of Junior Achievement and Edison Electric Institute CFO Committee. She was on the NJ Board of Trustee of Drumthwacket (NJ Governor’s Mansion).
Ms. Dorsa was the Executive VP & CFO at Public Service Enterprise Group, Inc. from 2009 until her retirement in 2015. She was responsible for finance, accounting, treasury, risk management, internal audit, strategy, corporate development and investor relations. Public Service Enterprise Group, Inc. is an integrated provider of regulated utility electric and gas distribution services.
Ms. Dorsa also worked at Gilead Sciences and Avaya as the Senior VP and CFO. She spent 21 years at Merck, including as a Senior VP of Global Human Health and for 13 years in the position of VP and Treasurer. Prior to working at Merck, Ms. Dorsa worked for the city of NY in the Finance organization and the Mayor’s Office.
Ms. Dorsa received her B.A. in History from Colgate University and her MBA in Finance and Accounting from Columbia University.